THE OPTIMAL DURATION OF CONSOLIDATION TREATMENT PRIOR TO CESSATION OF NUC THERAPY IN HBEAG-NEGATIVE PATIENTS

研究成果: 期刊稿件 › 文章 › 同行評審

引用此

@article{9d4920d7e83642559869496368b51b8c,

title = "THE OPTIMAL DURATION OF CONSOLIDATION TREATMENT PRIOR TO CESSATION OF NUC THERAPY IN HBEAG-NEGATIVE PATIENTS",

author = "Wen-Juei Jeng and Yi-Cheng Chen and I-Shyan Sheen and Rong-Nan Chien and Yun-Fan Liaw",

year = "2019",

language = "American English",

volume = "70",

journal = "Hepatology",

issn = "0270-9139",

publisher = "Lippincott Williams and Wilkins",

}